Topic

The innovative PMTCT B+ approach aims to place 2,000 HIV-positive pregnant women on treatment over the next four years.

More >

The prevalence of HIV among commercial sex workers in Nsanje, Malawi, is an alarming 82 percent; with no local response and a low supply of condoms in the district, sex workers are a driver of new infections.

More >

Harmful rules in the Trans-Pacific Partnership (TPP) trade deal will mean people in developing countries will have less access to lifesaving medicines.

More >

Forty young Malawians were awarded MSF scholarships to receive medical training and give back to their communities. 

More >

MSF is working to help fight the stigma associated with HIV/AIDS in Yemen.

More >

Micaela Serafini, MSF medical referent, discusses MSF’s efforts to treat HIV/AIDS in Swaziland.

More >

MSF helped organize a fashion show for women living with HIV to show what is possible when treatment is made available and to alert the public to the tragic lack of access to treatment in the country.

More >

After fighting forced a suspension of operations, MSF has returned to continue providing medical care in Shamwana, Katanga Province.

More >

Tens of thousands of people living with HIV and tuberculosis  in Myanmar are unable to access lifesaving antiretroviral therapy, a dire situation exacerbated by the recent cancellation of a new round of funding from the Global Fund to Fight AIDS, TB, and Malaria.

More >

On Monday, December 19, Johnson & Johnson is expected to announce whether it intends to license its patents on three lifesaving HIV/AIDS drugs to the Medicines Patent Pool, a mechanism designed to lower prices of HIV medicines and increase access to them for people in the developing world.

More >

Pages